| Year |
Citation |
Score |
| 2022 |
Agarwal HK, Chhikara BS, Ye G, Bhavaraju S, Dixit A, Kumar A, Doncel GF, Parang K. Synthesis and Biological Evaluation of 5'--Fatty Acyl Ester Derivatives of 3'-Fluoro-2',3'-dideoxythymidine as Potential Anti-HIV Microbicides. Molecules (Basel, Switzerland). 27. PMID 35630829 DOI: 10.3390/molecules27103352 |
0.642 |
|
| 2013 |
Mandal D, Tiwari RK, Shirazi AN, Oh D, Ye G, Banerjee A, Yadav A, Parang K. Self-Assembled Surfactant Cyclic Peptide Nanostructures as Stabilizing Agents. Soft Matter. 9. PMID 24187575 DOI: 10.1039/C3Sm50764E |
0.627 |
|
| 2012 |
Agarwal HK, Chhikara BS, Hanley MJ, Ye G, Doncel GF, Parang K. Synthesis and biological evaluation of fatty acyl ester derivatives of (-)-2',3'-dideoxy-3'-thiacytidine. Journal of Medicinal Chemistry. 55: 4861-71. PMID 22533850 DOI: 10.1021/Jm300492Q |
0.641 |
|
| 2010 |
Ye G, Gupta A, DeLuca R, Parang K, Bothun GD. Bilayer disruption and liposome restructuring by a homologous series of small Arg-rich synthetic peptides. Colloids and Surfaces. B, Biointerfaces. 76: 76-81. PMID 19913394 DOI: 10.1016/J.Colsurfb.2009.10.016 |
0.542 |
|
| 2009 |
Ye G, Schuler AD, Ahmadibeni Y, Morgan JR, Faruqui A, Huang K, Sun G, Zebala JA, Parang K. Synthesis and evaluation of phosphopeptides containing iminodiacetate groups as binding ligands of the Src SH2 domain. Bioorganic Chemistry. 37: 133-42. PMID 19539345 DOI: 10.1016/J.Bioorg.2009.05.003 |
0.585 |
|
| 2008 |
Ye G, Tiwari R, Parang K. Development of Src tyrosine kinase substrate binding site inhibitors. Current Opinion in Investigational Drugs (London, England : 2000). 9: 605-13. PMID 18516760 |
0.618 |
|
| 2007 |
Ye G, Nam NH, Kumar A, Saleh A, Shenoy DB, Amiji MM, Lin X, Sun G, Parang K. Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides. Journal of Medicinal Chemistry. 50: 3604-17. PMID 17580848 DOI: 10.1021/Jm070416O |
0.559 |
|
| 2006 |
Gu X, Wang Y, Kumar A, Ye G, Parang K, Sun G. Design and evaluation of hydroxamate derivatives as metal-mediated inhibitors of a protein tyrosine kinase. Journal of Medicinal Chemistry. 49: 7532-9. PMID 17149882 DOI: 10.1021/Jm061058C |
0.554 |
|
| 2006 |
Kumar A, Ye G, Ahmadibeni Y, Parang K. Synthesis of polymer-bound 4-acetoxy-3-phenylbenzaldehyde derivatives: applications in solid-phase organic synthesis. The Journal of Organic Chemistry. 71: 7915-8. PMID 16995713 DOI: 10.1021/Jo061328Z |
0.492 |
|
| 2006 |
Kumar A, Ye G, Wang Y, Lin X, Sun G, Parang K. Synthesis and structure-activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitors. Journal of Medicinal Chemistry. 49: 3395-401. PMID 16722659 DOI: 10.1021/Jm060334K |
0.589 |
|
| 2005 |
Ye G, Ayrapetov M, Nam NH, Sun G, Parang K. Solid-phase binding assays of peptides using EGFP-Src SH2 domain fusion protein and biotinylated Src SH2 domain. Bioorganic & Medicinal Chemistry Letters. 15: 4994-7. PMID 16169725 DOI: 10.1016/J.Bmcl.2005.08.005 |
0.599 |
|
| 2005 |
Ayrapetov MK, Nam NH, Ye G, Kumar A, Parang K, Sun G. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation. The Journal of Biological Chemistry. 280: 25780-7. PMID 15890649 DOI: 10.1074/Jbc.M504022200 |
0.549 |
|
| 2004 |
Nam NH, Lee S, Ye G, Sun G, Parang K. ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases. Bioorganic & Medicinal Chemistry. 12: 5753-66. PMID 15498652 DOI: 10.1016/J.Bmc.2004.08.043 |
0.578 |
|
| 2004 |
Schmidt B, Jiricek J, Titz A, Ye G, Parang K. Copper dipicolinates as peptidomimetic ligands for the Src SH2 domain. Bioorganic & Medicinal Chemistry Letters. 14: 4203-6. PMID 15261270 DOI: 10.1016/J.Bmcl.2004.06.018 |
0.576 |
|
| 2004 |
Nam NH, Ye G, Sun G, Parang K. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding. Journal of Medicinal Chemistry. 47: 3131-41. PMID 15163193 DOI: 10.1021/Jm040008+ |
0.602 |
|
| Show low-probability matches. |